In the SURMOUNT-1 trial, which included adults with obesity or overweight (without diabetes), participants achieved remarkable average weight loss over 72 weeks: At the 5 mg dose: Participants lost an average of 16% of their starting body weight
A 2023 paper in Pharmaceuticals (PMID: 37242459) documented anxiolytic, anticonvulsive, and antidepressant-like effects in animal behavioral assays and reported that BPC-157 attenuated benzodiazepine tolerance development and counteracted serotonin syndrome in rats
Some of the data were presented as a poster abstract at the 79th Scientific Sessions of the ADA, San Francisco, 710 June 2019 and as an oral abstract at the Obesity Week, Las Vegas, 37 November 2019
Managing initial irritation is straightforward
Without L-Carnitine, these fats cannot be burned for energy and are instead shunted to stored body fat.* BOOST ENERGY, ENDURANCE & PERFORMANCE L-Carnitine enhances performance by increasing the bodys reliance on fat for energy
Participants were recruited from the local community through local newspapers and social media advertisements, support groups, flyers in long COVID and ME/CFS care clinics between February 2020 and July 2022